Kathryn Ryans1, Marisa Perdomo2, Claire C Davies3, Kimberly Levenhagen4, Laura Gilchrist5. 1. Mercy College, Dobbs Ferry, NY, USA. kryans@mercy.edu. 2. University of Southern California, Los Angeles, CA, USA. 3. Baptist Health Lexington, Lexington, KY, USA. 4. Saint Louis University, St. Louis, MO, USA. 5. St. Catherine University, St. Paul, MN, USA.
Abstract
PURPOSE: A work group from the American Physical Therapy Association Academy of Oncologic Physical Therapy developed and published a clinical practice guideline (CPG) to aid clinicians in identifying interventions for individuals with breast cancer-related lymphedema (BCRL). This guideline reviewed the evidence for risk mitigation and volume reduction beginning at cancer diagnosis and continuing through survivorship. Application of CPGs can be challenging due to the variability of clinical settings, heterogeneous patient populations, and range of rehabilitation clinician expertise. The purpose of this paper is to assist these clinicians in implementing the recommendations from the CPG to develop a patient-centered, evidence-based plan of care. METHODS/ RESULTS: This publication presents important considerations for the implementation of recommended rehabilitation interventions across the trajectory of BCRL. CONCLUSION: Current evidence supports specific interventions to treat or mitigate the risk for the various stages of BCRL. As clinicians implement these recommendations into practice, they also need to address other impairments that may exist in every individual. Continued collaboration between clinicians and researchers is necessary to further develop optimal treatment modalities and parameters. IMPLICATIONS FOR CANCER SURVIVORS: By implementing evidence-based interventions as outlined in the CPG, clinicians can improve the quality of care for survivors of breast cancer.
PURPOSE: A work group from the American Physical Therapy Association Academy of Oncologic Physical Therapy developed and published a clinical practice guideline (CPG) to aid clinicians in identifying interventions for individuals with breast cancer-related lymphedema (BCRL). This guideline reviewed the evidence for risk mitigation and volume reduction beginning at cancer diagnosis and continuing through survivorship. Application of CPGs can be challenging due to the variability of clinical settings, heterogeneous patient populations, and range of rehabilitation clinician expertise. The purpose of this paper is to assist these clinicians in implementing the recommendations from the CPG to develop a patient-centered, evidence-based plan of care. METHODS/ RESULTS: This publication presents important considerations for the implementation of recommended rehabilitation interventions across the trajectory of BCRL. CONCLUSION: Current evidence supports specific interventions to treat or mitigate the risk for the various stages of BCRL. As clinicians implement these recommendations into practice, they also need to address other impairments that may exist in every individual. Continued collaboration between clinicians and researchers is necessary to further develop optimal treatment modalities and parameters. IMPLICATIONS FOR CANCER SURVIVORS: By implementing evidence-based interventions as outlined in the CPG, clinicians can improve the quality of care for survivors of breast cancer.
Entities:
Keywords:
Breast cancer; Interventions; Lymphedema
Authors: Nicole L Stout; Lucinda A Pfalzer; Barbara Springer; Ellen Levy; Charles L McGarvey; Jerome V Danoff; Lynn H Gerber; Peter W Soballe Journal: Phys Ther Date: 2011-09-15
Authors: Atilla Soran; Tolga Ozmen; Kandace P McGuire; Emilia J Diego; Priscilla F McAuliffe; Marguerite Bonaventura; Gretchen M Ahrendt; Lori DeGore; Ronald Johnson Journal: Lymphat Res Biol Date: 2014-12 Impact factor: 2.589
Authors: Nicole L Stout Gergich; Lucinda A Pfalzer; Charles McGarvey; Barbara Springer; Lynn H Gerber; Peter Soballe Journal: Cancer Date: 2008-06-15 Impact factor: 6.860
Authors: Kristin L Campbell; Kerri M Winters-Stone; Joachim Wiskemann; Anne M May; Anna L Schwartz; Kerry S Courneya; David S Zucker; Charles E Matthews; Jennifer A Ligibel; Lynn H Gerber; G Stephen Morris; Alpa V Patel; Trisha F Hue; Frank M Perna; Kathryn H Schmitz Journal: Med Sci Sports Exerc Date: 2019-11 Impact factor: 5.411
Authors: Louise A Koelmeyer; Robert J Borotkanics; Jessica Alcorso; Philip Prah; Caleb J Winch; Kristine Nakhel; Catherine M Dean; John Boyages Journal: Cancer Date: 2018-12-06 Impact factor: 6.860